1
|
Use, attitudes and knowledge of medications among pregnant women: A Saudi study. Saudi Pharm J 2013; 22:419-28. [PMID: 25473330 DOI: 10.1016/j.jsps.2013.09.001] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2013] [Accepted: 09/28/2013] [Indexed: 11/22/2022] Open
Abstract
OBJECTIVE Medication use during pregnancy is a major concern for most women. The aim of the present study was to assess medication use, knowledge and beliefs about medications among pregnant women in Saudi Arabia. METHODS More than 760 pregnant women, attending the obstetric clinic, filled a semi-structured questionnaire. Data were collected about their sociodemographic background, medication use during pregnancy, medication/pregnancy risk awareness, sources of drug information and beliefs about medications. RESULTS Most women had a positive attitude toward medications in general but they believed pregnant women should be more cautious regarding drug-use during pregnancy. A significant association was found between participants' education and occupation, and beliefs about medications. In this context, well educated women and those working in a health-related career demonstrated more correct beliefs about medications. Women with health-related occupations were more knowledgeable about the life saving effect of drugs on unborn children. Women indicated inadequate provision of drug-related information from physician and pharmacist; they rely on medication pamphlet to get such information. The most frequently used drugs were paracetamol and vitamins (13.2%). Most pregnant women (59.2%) were able to identify drugs to-be avoided in pregnancy that agreed roughly with FDA categories with 23 hits out of 32. They indicated that newborn anomalies (6.5%) were not attributed to drug-use during pregnancy. CONCLUSION During pregnancy, women were more conservative and skeptic toward medication, health-care professionals should be aware of such attitudes when advising pregnant women to take medication.
Collapse
|
3
|
Lapi F, Vannacci A, Moschini M, Cipollini F, Morsuillo M, Gallo E, Banchelli G, Cecchi E, Di Pirro M, Giovannini MG, Cariglia MT, Gori L, Firenzuoli F, Mugelli A. Use, Attitudes and Knowledge of Complementary and Alternative Drugs (CADs) Among Pregnant Women: a Preliminary Survey in Tuscany. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE : ECAM 2010; 7:477-86. [PMID: 18955336 PMCID: PMC2892351 DOI: 10.1093/ecam/nen031] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/06/2007] [Accepted: 04/04/2008] [Indexed: 11/24/2022]
Abstract
To explore pregnant women's use, attitudes, knowledge and beliefs of complementary and alternative drugs (CADs) defined as products manufactured from herbs or with a natural origin. A preliminary survey was conducted among 172 pregnant women in their third trimester of pregnancy, consecutively recruited in two obstetrical settings; 15 women were randomly selected to compute a test-to-retest analysis. Response rate was 87.2%. Test-to-retest analysis showed a questionnaire's reproducibility exceeding a K-value of 0.7 for all items. Mean age was 32.4 ± 0.4 years; most women were nulliparae (62.7%). The majority of subjects (68%) declared to have used one or more CADs during their lifetime; 48% of pregnant women reported taking at least one CAD previously and during the current pregnancy. Women's habitual use of CADs meant they were at higher risk of taking CADs also during pregnancy (adjusted odds ratio = 10.8; 95% confidence interval: 4.7-25.0). Moreover, 59.1% of the subjects were unable to correctly identify the type of CADs they were using. The majority of women resorted to gynecologists as the primary information source for CADs during pregnancy, while they mainly referred to herbalists when not pregnant. Habitual use of CADs seems to be a strong predictor for their ingestion also during pregnancy; in addition most subjects were unable to correctly identify the products they were taking. In the light of the scanty data concerning the safety of CADs during pregnancy, these preliminary results confirm the need to investigate thoroughly the situation of pregnant women and CADs consumption.
Collapse
Affiliation(s)
- Francesco Lapi
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Alfredo Vannacci
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Martina Moschini
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Fabrizio Cipollini
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Maria Morsuillo
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Eugenia Gallo
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Grazia Banchelli
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Enrica Cecchi
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Marina Di Pirro
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Maria Grazia Giovannini
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Maria Teresa Cariglia
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Luigi Gori
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Fabio Firenzuoli
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| | - Alessandro Mugelli
- Tuscan Regional Centre of Pharmacovigilance, Department of Preclinical and Clinical Pharmacology, Florence, Department of Statistical Science, University of Florence, Department of Emergency Medicine, ASL 4 Hospital, Prato and Centre of Natural Medicine, ASL 11 Hospital, Empoli, Italy
| |
Collapse
|